Literature DB >> 17274959

Role of astrocytes in grey matter during stroke: a modelling approach.

Marie-Aimée Dronne1, Emmanuel Grenier, Thierry Dumont, Marc Hommel, Jean-Pierre Boissel.   

Abstract

The astrocytic response to stroke is extremely complex and incompletely understood. On the one hand, astrocytes are known to be neuroprotective when extracellular glutamate or potassium is slightly increased. But, on the other hand, they are considered to contribute to the extracellular glutamate increase during severe ischaemia. A mathematical model is used to reproduce the dynamics of the membrane potentials, intracellular and extracellular concentrations and volumes of neurons and astrocytes during ischaemia in order to study the role of astrocytes in grey matter during the first hour of a stroke. Under conditions of mild ischaemia, astrocytes are observed to take up glutamate via the glutamate transporter, and potassium via the Na/K/Cl cotransporter, which limits glutamate and potassium increase in the extracellular space. On the contrary, under conditions of severe ischaemia, astrocytes appear to be unable to maintain potassium homeostasis. Moreover, they are shown to contribute to the excitotoxicity process by expelling glutamate out of the cells via the reversed glutamate transporter. A detailed understanding of astrocytic function and influence on neuron survival during stroke is necessary to improve the neuroprotective strategies for stroke patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17274959     DOI: 10.1016/j.brainres.2006.12.062

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Dependence of spontaneous neuronal firing and depolarisation block on astroglial membrane transport mechanisms.

Authors:  Leiv Øyehaug; Ivar Østby; Catherine M Lloyd; Stig W Omholt; Gaute T Einevoll
Journal:  J Comput Neurosci       Date:  2011-06-11       Impact factor: 1.621

2.  Towards a dynamical network view of brain ischemia and reperfusion. Part IV: additional considerations.

Authors:  Donald J Degracia
Journal:  J Exp Stroke Transl Med       Date:  2010-03-15

3.  Towards a dynamical network view of brain ischemia and reperfusion. Part III: therapeutic implications.

Authors:  Donald J Degracia
Journal:  J Exp Stroke Transl Med       Date:  2010

4.  Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson's disease.

Authors:  Tahira Farooqui; Akhlaq A Farooqui
Journal:  Parkinsons Dis       Date:  2011-02-15

5.  The neuroglial potassium cycle during neurotransmission: role of Kir4.1 channels.

Authors:  Jérémie Sibille; Khanh Dao Duc; David Holcman; Nathalie Rouach
Journal:  PLoS Comput Biol       Date:  2015-03-31       Impact factor: 4.475

6.  A methodological framework for drug development in rare diseases.

Authors:  Patrice Nony; Polina Kurbatova; Agathe Bajard; Salma Malik; Charlotte Castellan; Sylvie Chabaud; Vitaly Volpert; Nathalie Eymard; Behrouz Kassai; Catherine Cornu
Journal:  Orphanet J Rare Dis       Date:  2014-11-18       Impact factor: 4.123

7.  Ceftriaxone preserves glutamate transporters and prevents intermittent hypoxia-induced vulnerability to brain excitotoxic injury.

Authors:  Rekha Jagadapillai; Nicholas M Mellen; Leroy R Sachleben; Evelyne Gozal
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.